関連する実験動画
Updated: Jul 13, 2026

14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 5, 2010
喘息の悪化における緩和療法のためのフォームテロールと併用されたブデソニドの効果:ランダム化され,制御され,ダブルブラインド試験
Klaus F Rabe1, Tito Atienza, Pál Magyar
1Department of Pulmonology, University of Leiden, Leiden, Netherlands. K.F.Rabe@lumc.nl
Lancet (London, England)
|August 29, 2006
まとめ
必要に応じてブデソニド-フォルモテロールを使用すると,フォルモテロールまたはテルブタリンと比較して,重度の喘息悪化が著しく減少しました. この組み合わせ療法により,維持治療を受けている患者の保護が強化されます.
科学分野:
- 肺内科 肺内科 肺内科
- 薬理学 薬理学とは
- クリニック・トライアル 臨床試験
背景:
- 喘息管理における必要な吸入型コルチコステロイド (ICS) と長効β2アゴニスト (LABA) の役割については,さらなる明確化が必要である.
- この研究では,メンテナンス療法を受けている症状性喘息患者の3つの緩和策が調査されました.
研究 の 目的:
- ブデソニド・フォルモテロール維持療法の症状性喘息の患者で,必要に応じて3つの緩和薬の有効性と安全性を比較する.
- 最初の重度の喘息悪化までの時間を評価し,その他の関連するアウトカム.
主な方法:
- 12ヶ月のダブルブラインド並列グループ研究で,12歳以上の3394人の患者が参加した.
- 患者はブデソニド・フォルモテロール維持療法と,必要に応じてテルブタリン,フォルモテロール,またはブデソニド・フォルモテロールを受けた.
- 主要アウトカム:最初の重症悪化までの時間 (入院,緊急治療,または長期の経口ステロイド使用).
主要な成果:
- 必要に応じてブデソニド-フォルモテロールは,フォルモテロールとテルブタリンと比較して,最初の重症悪化までの時間を大幅に増加させた.
- 重度の悪化率は,必要に応じてブデソニド-フォルモテロール,フォルモテロール,およびテルブタリンを投与した患者年100人に19,29,および37であった.
- 喘息のコントロールの日々は,グループごとに同様に改善されました; 必要に応じてホルモテロールは,テルブタリンよりも症状を大幅に改善しませんでした.
結論:
- 必要に応じてブデソニド・フォルモテロールは,維持性併用療法を受けている患者の重度の喘息悪化に対する強化された保護を提供します.
- ブデソニド・フォルモテロールの2つの成分は,緩和剤として使用すると,この保護効果に貢献します.
- 試験されたすべての治療法は,患者によって良好に耐えた.
関連する概念動画
Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Antiasthma Drugs: β2-Adrenoceptor Agonists
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Asthma-IV: Diagnostic and Management
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Inhaled Medications
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...

